DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20174947

A double blind, randomized, placebo controlled, phase IV, proof-of-concept, comparative study to evaluate the efficacy and safety of Swasawin asthaloc tablets when given as add-on therapy in patients suffering from mild to moderate persistent bronchial asthma

Shilpa P. Karande, Renuka P. Munshi, Dipti A. Kumbhar

Abstract


Background: Asthma, known as “Tamaka Shwasa” in Ayurveda, as a chronic inflammatory disorder of the airways associated with increased airway hyper-responsiveness, recurrent episodes of wheezing, breathlessness, chest tightness and coughing, particularly at night/early morning. The key component to improving control and preventing attacks is the avoidance of triggers. Swasawin Asthaloc tablet, a polyherbal proprietary medication, is claimed to be effective in asthma. The Objective of the study was to evaluate the safety and efficacy of Swasawin Asthaloc tablets when given as add-on therapy to patients suffering from mild to moderate persistent bronchial asthma.

Methods: The study was initiated after receiving Institutional Ethics Committee approval. Patients suffering from mild-to-moderate persistent bronchial asthma were randomized to 2 study groups after written informed consent process for 6 months. Group I received the study medication Swasawin Asthaloc tablet (1 tablet twice daily) in addition to regular anti-asthmatic medications (inhaler ± oral medications). Group II received Placebo tablets in a similar dose as add-on therapy. The study efficacy parameters included spirometry, breath holding time (BHT), Asthma symptom score and Ayurvedic Asthma symptom score.

Results: 60 patients were enrolled in the study, of which 50 patients completed the study. In case of spirometry, both FEV1 and PEFR values showed statistically significant improvement at the end of 6 months therapy. Significant improvement in the Breath Holding Time (BHT), Ayurvedic Asthma symptom score and Asthma symptom score was observed in the active group as compared to the baseline (p <0.001).

Conclusions: Add-on therapy with Swasawin Asthaloc tablets helped in reducing bronchial inflammation and improving asthmatic symptoms by virtue of its anti-inflammatory, bronchodilatory and antihistaminic properties. Hence it can be used as add-on therapy in patients with mild-to-moderate persistent bronchial asthma and may decrease the need for rescue medications especially steroids.


Keywords


Bronchial Asthma, Breath holding time (BHT), FEV1, PEFR, Spirometry, Swasawin asthaloc tablets

Full Text:

PDF

References


17th Adhyaya, Chikitsasthana Charak Samhita, Shloka no.75, Ed. Acharya Jadavji Trikamaji, 5th edition, Chaukhamba Sanskrit Sansthan, Varanasi 2001, pg.536.

Gogte VVM. Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants (Dravyagunavidnyan), Bhartiya Vidya Bhavan, Mumbai, First English Edition Oct 2000, p.g no. 313, 327,331, 424,450,457, 459,468, 519, 726.

Tripathy KD. Essentials of Medical Pharmacology; Jaypee Brothers. New Delhi:5th ed; 2003. pp. 198-209.

Srimal RC, Sharma SC, Tendon JS. Anti inflammatory and other pharmacological effect of Hedychiumspicatum. Indian J Pharmacol. 1994;16:143-7.

Mahammad Y, Mahamad I. Anti histaminic herbal drugs: A review. Int J Pharm Pharm Sci. 2010;2:28-9.

Panda A, Doddanagali SR. Clinical efficacy of herbal Padmapatradi yoga in bronchial asthma (Tamakashwasa) J Ayurveda Integr Med. 2011;2:85-90.

Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E, Pharmacological studies on ginger. I. Pharmacological actions of pungent constitutents, (6)-gingerol and (6)-shogaol. J Pharmacobiodyn. 1984;7(11):836-48

Asami A, Shimada T, Mizuhara Y, Asano T, Takeda S, Aburada T, et al. Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I). J Natural Medic. 2010;64(3):281-7.

Amit A, Saxena VS, Pratibha N, D'Souza P, Bagchi M, Bagchi D, et al. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis., Drugs Exp Clin Res. 2003;29(3):107-15.

Choudhary GP. Mass cell stabilizing activity of Piper longum Linn. Indian J Allerg Asthma Immunol. 2006;20:112-6.

Chauhan K, Phytochemical and therapetics Potential of Piper Longum Linn-A Review, IJRAP. 2011;2(1) 157-61

Pathak AK, Nainwal N, Goyal BM, Singh R, Mishra V, Nayak S, et al. Pharmacological activity of Trachyspermumammi: A Review; J Pharmac Res. 2014;3(4):895-9.

Gholamnezhad Z, Byrami G, Boskabady MH, Iranshahi M. Possible mechanism (s) of the relaxant effect of asafoetida (Ferula assa-foetida) oleo-gum-resin extract on guinea-pig tracheal smooth muscle. Avicenna J Phytomedic. 2011;2(1):10-6.

Reddy NM, Rajasekhar Reddy N. Solanumxanthocarpum Chemical Constituents and Medicinal Properties: A Review, Sch Acad J Pharm. 2014;3(2):146-9.

Gohel SD, Anand IP, Patel KS. A comparative study on efficacy of Bharangyadi Avaleha and Vasa Avaleha in the management of Tamaka Shwasa with reference to childhood asthma. Ayu. 2011;32(1):82.

Kumar S, Agnihotri VK, Thakur S, Verma A, Saxena RC, Soni KK. Some important medicinal plants used in the treatment of asthma-a review. Int. J Pharma Sci Res. 2012;3(10):500-2.

Tarai A, Sahoo A, Mandal PK, Jena J. Antiasthmaticeffect of Glycrrhizaglabra against histamine induced bronchospasm in guinea pigs. International J Pharmaceutic Phytopharmacologic Res. 2013;2(5):389-390.

Omwamba M, Hu Q. Antioxidant activity in barley (HordeumVulgare L.) grains roasted in a microwave oven under conditions optimized using response surface methodology. J Food Sci. 2010;75(1):C66-73.

Uddin G, Rauf A. In Vitro Antimicrobial Profile of PistaciaIntegerrima Galls Stewart Asian Pac J Trop Biomed. 2012;1:1-3

Srivastava S, Gupta PP, Prasad R, Dixit KS, Palit G, Ali B, et al. Evaluation of antiallergic activity (type I hypersensitivity) of Inularacemosa in rats. Indian J Pharmacol. 1999;43:235-41

Padmanabha Rao A, Jamil K. Pharmacological evaluation of herbal extracts for their invitro hypoglycemic activity, Internat J Phytopharmacol. 2011;2(1):15-21.

Singh MK, Khare G, Iyer SK, Sharwan G Tripathi DK; Clerodendrumserratum: A clinical approach; Journal of Applied Pharmaceutical Science. 2012; 2(2):11-5

Sai Krishna. G. “Tulsi” - the Wonder Herb (Pharmacological Activities of Ocimum Sanctum), American Journal of Ethnomedicine. 2014;1(1):89-95.